ExploraMed

ExploraMed is a premier medical device incubator and venture studio focused on identifying significant unmet clinical needs and developing innovative therapeutic solutions. Founded in 1995 by Dr. Josh Makower, the firm operates by creating, funding, and managing new medical technology companies through their early development stages. ExploraMed has successfully launched several high-profile companies, including Acclarent (acquired by Johnson & Johnson), NeoTract (acquired by Teleflex), and Moximed. The incubator's approach combines clinical insight with engineering expertise to address conditions in ENT, urology, orthopedics, and women's health. It maintains a long-standing strategic partnership with New Enterprise Associates (NEA) to support its portfolio companies from inception to exit. The firm is widely recognized for its 'Biodesign' methodology, which has become a standard for medical technology innovation.